lobbying_activities: 591637
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 591637 | 9142b91f-42dc-4610-a595-371866a3e3aa | Q1 | KNIGHT CAPITOL CONSULTANTS | 40036301 | GENZYME CORPORATION | 2008 | first_quarter | PHA | S.1695 : A bill to amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2008-04-16T11:54:11-04:00 |